Companies founded on innovation and strong science

Calluna Pharma

Calluna Pharma is a clinical stage company pioneering a breakthrough approach to treating inflammatory and fibrotic diseases by leveraging the body’s innate immune system. The Company’s therapeutic approach targets upstream amplifiers of disease, offering potential applicability across a diverse array of medical conditions.

Calluna Pharma

Sector: Biotechnology
Country: Norway/Netherlands
Year of first investment: 2023
Status: Active
Calluna Pharma